These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Combined treatment with intra-arterial administration of oily anti-cancer agents and transcatheter arterial embolization--clinical and pathological study on 2 cases with resected small hepatoma]. Tokuyama K, Jinno K, Yumoto Y, Takasima S, Fukuda K, Moriwaki S, Maeda H, Shimamura Y. Gan No Rinsho; 1984 Jul; 30(8):955-64. PubMed ID: 6088831 [Abstract] [Full Text] [Related]
27. [Advantages and disadvantages of SMANCS-Lipiodol intrahepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma]. Suzuki M, Fukuhara K, Unno M, Endoh K, Takeuchi H, Kodama H, Oikawa M, Matsuno S. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():39-45. PubMed ID: 9512686 [Abstract] [Full Text] [Related]
28. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol]. Inoue Y, Nakamura H. Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478 [Abstract] [Full Text] [Related]
29. [Combination of transcatheter arterial infusion of SMANCS and embolization on hepatocellular carcinoma]. Hirashima N, Kumada K, Sakakibara K, Hirai T, Nemoto S, Matsuura H, Itazu I, Nojiri O, Kano H. Gan To Kagaku Ryoho; 1995 Sep; 22(10):1411-5. PubMed ID: 7668880 [No Abstract] [Full Text] [Related]
32. Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride. Sohara N, Takagi H, Abe T, Hashimoto Y, Kojima A, Takahashi H, Nagamine T, Mori M. Support Care Cancer; 1999 Mar; 7(2):84-8. PubMed ID: 10089088 [Abstract] [Full Text] [Related]
33. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer]. Ohtsuka N, Konno T. Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992 [Abstract] [Full Text] [Related]
34. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma]. Inoue Y, Tomoda K, Oi H, Nakamura H. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689 [Abstract] [Full Text] [Related]
35. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol]. Konno T, Tabaru K, Isogai M, Nagamitsu A, Oda T. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681 [Abstract] [Full Text] [Related]
36. [A case of massive hepatoma which responded to SMANCS/Lipiodol regimen with intra-arterial infusion]. Kubo M, Fuchigami T, Murata S, Konno T, Maeda H. Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2953-6. PubMed ID: 2551233 [Abstract] [Full Text] [Related]